DIALIMEDA, UAB - financials and debts

Company age: 25 y. 6 mo.

Update

DIALIMEDA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 805,336 872,584 963,856 946,633 938,680 959,497 1,080,105 1,123,647
Profit before tax 82,579 62,629 74,337 182,501 42,398 97,051 98,130 81,899
Net profit 79,237 60,759 72,923 180,216 40,152 92,591 95,224 54,817
Equity 1,281,538 964,714 1,050,908 1,224,635 1,234,770 1,157,362 1,259,687 1,196,672
Liabilities 427,007 352,566 256,879 187,361 126,001 131,819 179,555 245,048
Non-current assets 1,501,702 1,114,919 979,601 991,823 1,034,413 836,252 972,265 836,805
Current assets 231,915 219,829 365,901 453,344 357,298 551,327 542,163 670,166
Total assets 1,733,617 1,334,748 1,345,502 1,445,167 1,391,711 1,387,579 1,514,428 1,506,971
Taxes paid
STI taxes - - - - - 96,459 112,518 113,409
Social insurance contributions - - - - - 108,749 121,229 126,510
Financial indicators
Revenue change y/y +1.4% +8.4% +10.5% -1.8% -0.8% +2.2% +12.6% +4.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 4.6% 4.6% 5.4% 12.5% 2.9% 6.7% 6.3% 3.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 6.2% 6.3% 6.9% 14.7% 3.3% 8.0% 7.6% 4.6%
Profit margin Net profit margin. Shows the overall profitability of the company. 9.8% 7.0% 7.6% 19.0% 4.3% 9.6% 8.8% 4.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 10.3% 7.2% 7.7% 19.3% 4.5% 10.1% 9.1% 7.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.4 0.2 0.2 0.1 0.1 0.1 0.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 36,606 37,665 45,358 42,866 36,691 36,322 41,543 44,209

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

DIALIMEDA - Social security debts

From To Debt, €
2025-10-23 2025-11-09 2.69
2025-05-04 2025-05-07 2.13
2025-04-24 2025-04-29 2.13
2022-07-18 2022-07-19 188.50

DIALIMEDA - VMI tax arrears

From To Overdue, €
2026-03-02 2026-03-02 69.06
2025-10-08 2025-10-08 81.53
2025-05-01 2025-05-08 0.44
2025-02-05 2025-02-10 355.79
2025-02-02 2025-02-04 355.39
2025-01-31 2025-02-01 351.9
2024-09-29 2024-10-09 13.16

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
DIALIMEDA, UAB (code 167348221) is a Private Limited Liability Company engaged in activities of specialised hospitals. In 2025, the company generated revenue of €1.12M, up 4.0% year on year and 17.1% over two years. Net profit amounted to €54.8K, compared with €95.2K in 2024 and €92.6K in 2023, showing that profitability weakened despite continued sales growth. The profit margin declined from 9.6% in 2023 to 8.8% in 2024 and 4.9% in 2025.

The balance sheet remained solid in 2025, with total assets of €1.51M, equity of €1.20M and liabilities of €245.0K. The equity ratio stood at 79.4% and debt-to-equity at 0.20, indicating a conservative capital structure. Return on equity was 4.6% and return on assets 3.6%, while asset turnover was 0.75x. Revenue per employee reached €44.9K and profit per employee €2.2K, suggesting moderate productivity in the latest year.